Accumulation of 131Iodine in the nasolacrimal sac/duct after radioiodine therapy for papillary thyroid cancer.
Usmani S, Jain A, Al-Riyami K, Abubakar S.
J Pak Med Assoc. 2023 Mar;73(3):713-714. doi: 10.47391/JPMA.23-22.
PMID:36932793
Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma.
Kubo N, Kubota Y, Kawamura H, Oike T, Sakai M, Kumazawa T, Miyasaka Y, Okazaki S, Kobayashi D, Sato H, Mizukami T, Musha A, Shirai K, Saitoh JI, Yokoo S, Chikamatsu K, Ohno T, Nakano T.
Radiother Oncol. 2019 Dec;141:72-77. doi: 10.1016/j.radonc.2019.07.022. Epub 2019 Aug 19.
PMID:31439449
Pleomorphic Adenoma of the Nasolacrimal Duct.
Haft SJ, Jafari A, Lowenthal BM, Korn BS, DeConde AS.
JAMA Otolaryngol Head Neck Surg. 2018 Sep 1;144(9):849-851. doi: 10.1001/jamaoto.2018.1448.
PMID:30054608
Endoscopic marsupialization of nasolacrimal duct cysts under topical anaesthesia: 5 years of a single institute experience.
Biadsee A, Dagan O, Kassem F, Ben-Dov T, Ebner Y.
Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110303. doi: 10.1016/j.ijporl.2020.110303. Epub 2020 Aug 8.
PMID:32805492
Nasolacrimal duct obstruction caused by lymphoproliferative infiltration in the course of chronic lymphocytic leukemia.